0000904454-19-000147.txt : 20190204
0000904454-19-000147.hdr.sgml : 20190204
20190204163240
ACCESSION NUMBER: 0000904454-19-000147
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190204
DATE AS OF CHANGE: 20190204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIGHAM MICHAEL
CENTRAL INDEX KEY: 0001216917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36066
FILM NUMBER: 19564098
MAIL ADDRESS:
STREET 1: 890 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 PARK PLAZA
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 807-6600
MAIL ADDRESS:
STREET 1: 75 PARK PLAZA
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc
DATE OF NAME CHANGE: 20090130
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-02-01
0001178711
Paratek Pharmaceuticals, Inc.
PRTK
0001216917
BIGHAM MICHAEL
C/O PARATEK PHARMACEUTICALS, INC.
75 PARK PLAZA, 4TH FLOOR
BOSTON
MA
02116
1
1
0
0
Chairman and CEO
Common Stock
2018-06-21
5
G
0
20050
0
D
236417
D
Common Stock
2019-02-01
4
A
0
35000
0
A
271417
D
Represents performance-based restricted stock units ("PRSUs") granted on February 14, 2018 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, which were earned on February 1, 2019. These PRSUs will settle in shares of Common Stock on May 8, 2020, provided that the Reporting Person remains in continuous service with Paratek Pharmaceuticals, Inc. through the settlement date.
/s/ William M. Haskel, Attorney-in-Fact for Michael Bigham
2019-02-04